The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes

In this study we investigate pyridoxamine (PM) and/or sulforaphane (SFN) as therapeutic interventions to determine whether activators of NFE2-related factor 2 (Nrf2) can be used in addition with inhibitors of advanced glycation end products (AGE) formation to attenuate oxidative stress and improve e...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Ana, Fernandes, Rosa, Crisóstomo, Joana, Seiça, Raquel M., Sena, Cristina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662716/
https://www.ncbi.nlm.nih.gov/pubmed/29085055
http://dx.doi.org/10.1038/s41598-017-14733-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662716/
https://www.ncbi.nlm.nih.gov/pubmed/29085055
http://dx.doi.org/10.1038/s41598-017-14733-x

Ejemplares similares